ADC	Antibody drug-conjugates
CAR-T	Chimeric antigen receptor T cells
Fab	Fragment antigen binding
GM-CSF	Granulocyte-macrophage colony-stimulating factor
GPI	Glycosylphosphatidylinositol
GVAX	GM-CSF gene-transfected tumor cell vaccine
mAb	Monoclonal antibody
MAV	Metabolic Active Volume
MPF	Megakaryocyte-potentiating factor
MSLN	Mesothelin
MUC16	Mucin 16
OCT-2	Homeobox transcription factors POU2F2
OS	Overall survival
PD-1	programm death 1
PD-L1	programm death ligand 1
PD	Progressive disease
PDAC	Pancreatic ductal adenocarcinoma
PR	Partial response
RECIST	Response Evaluation Criteria in Solid Tumors
RTK	Receptor Tyrosine Kinase
SD	Stable disease
SMRP	Serum mesothelin-related peptide
Tat	Targeted alpha therapy